ANIX

Anixa Biosciences Inc

2.65

Jun 26 • 11:49AM ET +0.03 (1.15%)

Healthcare Biotechnology USA Micro NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	5.45%	Shs Outstand	33.92M	Perf Week	-8.93%
Market Cap	90.16M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	1.86%	Shs Float	32.17M	Perf Month	0.00%
Enterprise Value	75.40M	PEG	-	EPS next Q	-0.08	Inst Own	14.97%	Short Float	2.50%	Perf Quarter	0.76%
Income	-10.03M	P/S	-	EPS this Y	3.92%	Inst Trans	-2.96%	Short Ratio	5.98	Perf Half Y	-19.70%
Sales	0.00M	P/B	6.21	EPS next Y	-3.06%	ROA	-63.02%	Short Interest	0.80M	Perf YTD	-15.06%
Book/sh	0.43	P/C	6.59	EPS next 5Y	-2.86%	ROE	-65.70%	52W High	5.46 -51.43%	Perf Year	-21.60%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-68.66%	52W Low	2.32 14.22%	Perf 3Y	-18.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.76% 7.03%	Perf 5Y	-33.58%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.64%	Oper. Margin	-	ATR (14)	0.19	Perf 10Y	-16.14%
Dividend Ex-Date	-	Quick Ratio	9.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.83	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.79	EPS Q/Q	13.51%	SMA20	2.00%	Beta	0.61	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-4.85%	Rel Volume	15.33	Prev Close	2.62
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-19.60%	Avg Volume	134.39K	Price	2.65
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	800,673	Change	1.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)